S100b protects IMR-32 cells against Ab(1-42) induced neurotoxicity via modulation of apoptotic genes expression

Journals Menu

Follow SCIRP

ISSN Print: 2169-2459
ISSN Online: 2169-2467
www.scirp.org/journal/aad
E-mail: aad@scirp.org

"S100b protects IMR-32 cells against Ab(1-42) induced neurotoxicity via modulation of apoptotic genes expression"
written by M. Elisabetta Clementi, Beatrice Sampaolese, Doriana Triggiani, Antonio Tiezzi, Bruno Giardina,
published by Advances in Alzheimer's Disease, Vol.2 No.3, 2013

has been cited by the following article(s):

[1]	Growing role of S100B protein as a putative therapeutic target for neurological-and nonneurological-disorders
	2021

[2]	Biodistribution and amyloid beta induced cell line toxicity study of intranasal Rivastigmine microemulsion enriched with Fish Oil and Butter oil
	2020

[3]	S100 Proteins in Alzheimer's Disease
	2019

[4]	S100b Induces Expression of Myoglobin in APβ Treated Neuronal Cells In Vitro: A Possible Neuroprotective Mechanism
	Current Aging Science, 2016

[5]	Istituto di Chimica del Riconoscimento Molecolare–CNR PUBBLICAZIONI 2013
	2013

[1]	Studies on pomegranate seed oil enriched galantamine hydrobromide microemulsion: formulation, in vitro antioxidant and neuroprotective potential Pharmaceutical Development and Technology, 2023 DOI:10.1080/10837450.2023.2171433

[2]	Studies on pomegranate seed oil enriched galantamine hydrobromide microemulsion: formulation, in vitro antioxidant and neuroprotective potential Pharmaceutical Development and Technology, 2023 DOI:10.1080/10837450.2023.2171433

[3]	Studies on pomegranate seed oil enriched galantamine hydrobromide microemulsion: formulation, in vitro antioxidant and neuroprotective potential Pharmaceutical Development and Technology, 2023 DOI:10.1080/10837450.2023.2171433

[4]	Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders Neuroscience & Biobehavioral Reviews, 2021 DOI:10.1016/j.neubiorev.2021.04.035

[5]	Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders Neuroscience & Biobehavioral Reviews, 2021 DOI:10.1016/j.neubiorev.2021.04.035

[6]	Biodistribution and amyloid beta induced cell line toxicity study of intranasal Rivastigmine microemulsion enriched with Fish Oil and Butter oil Journal of Drug Delivery Science and Technology, 2020 DOI:10.1016/j.jddst.2020.101661

[7]	S100 Proteins in Alzheimer’s Disease Frontiers in Neuroscience, 2019 DOI:10.3389/fnins.2019.00463

Follow SCIRP